Arvinas Competitors and Similar CompaniesClear all

Arvinas's competitors and similar companies include Lyell.
Arvinas
Arvinas
Arvinas is a biopharmaceutical company focused on developing protein degradation therapeutics for cancers and other diseases.
Lyell
Lyell
Lyell Immunopharma is a T-cell reprogramming company to cure patients with solid tumors.
Type
Type
Public
Type
Public
Tags
Locations
Locations
New Haven, US HQ
Locations
South San Francisco, US HQ
Bothell, US
Seattle, US
Employees
Employees
13329% increase
Employees
188
Valuation ($)
Valuation ($)
1.9 b
Valuation ($)
243.3 m

Financial

Revenue (est.)
Revenue (est.)
$78.5m (FY, 2023)
Revenue (est.)
$130k (FY, 2023)
Net income
Net income
($367.3m) (FY, 2023)
Net income
($234.6m) (FY, 2023)
For sources of this data, please see the company profile

View Company Profiles

Lyell
HQ
South San Francisco, US
Employees
188

Lyell Immunopharma is a T-cell reprogramming company to cure patients with solid tumors.

View company